During the past 2 years, guidelines have shifted their recommendations on use of DTG around the time of conception and during pregnancy. As data and guidance evolve, which ART regimens should we recommend to PWH in these settings?
Certain INSTIs and TAF are associated with excessive weight gain in PWH. Here’s my take on what we know, what we don’t, and the need for clinical trials to assess mechanism and management strategies.
Here’s my take on what clinicians who treat HIV need to know about bone loss risk and bone health screening in our patients.
Data from 2020 conferences have shed new light on the issues of ARV-associated weight gain and ART safety during conception and pregnancy. Here are expert answers to your outstanding questions.